<DOC>
	<DOCNO>NCT01159782</DOCNO>
	<brief_summary>We , investigator , hypothesise distinct gene profile rhinovirus-induced acute exacerbation asthma . We hypothesise change gene expression involve know mediator asthma phenotype well molecules previously associate asthma . The primary objective study use gene array analysis determine differentially express gene bronchial epithelial cell alveolar macrophage normal asthmatic subject rhinovirus infection vivo . A secondary objective determine whether altered expression related symptom severity , virus load , lung function airway inflammation vivo . We plan recruit 45 subject : 15 healthy volunteer , 15 asthmatic naïve inhale corticosteroid therapy , 15 asthmatic inhaled corticosteroid undergo two bronchoscopies , one prior infection rhinovirus second 4 day post inoculation . Bronchial brushing , biopsy bronchoalveolar lavage ( BAL ) perform . RNA extract TRIzol reagent ( Invitrogen , Carlsbad , CA ) purify passage RNeasy column ( Qiagen , Valencia , CA ) . Exon 1.0ST array chip ( Affymetrix , Santa Clara , CA ) use analyse change gene expression . These powerful genome expression tool available 1.4 million probe set 5.5 million feature per array . Genes find significantly upregulated confirmed quantitative RT-PCR . Using novel method collect undiluted bronchial epithelial lining fluid ( bronchosorption ) large number protein measure MesoScale Discovery multiplexed array system ( MesoScale Discovery , Gaithersburg , Md ) allow confirmation gene array result well provide vivo evidence dysregulated protein production asthmatic . Gene expression protein level correlate viral load , symptom score , lung function airway inflammation vivo . This study represent first comprehensive evaluation change bronchial epithelial gene expression rhinovirus infection vivo therefore potential provide significant insight host response asthma identify potential novel target evaluation .</brief_summary>
	<brief_title>Mechanisms Rhinovirus Induced Asthma Exacerbations</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Inclusion Criteria atopic asthmatic : Age 1855 year Doctor diagnosis Asthma PC20 &lt; 8 µg/ml worsen asthma symptom infection since last change asthma therapy . Atopic skin test Treatment comprise short act beta agonist ( SABA ) ( steroid naïve group ) SABA + inhale corticosteroid ( ICS ) * ( steroid treat group ) subject inhaled corticosteroid must daily dose 100mcg 1000mcg fluticasone equivalent . Smoking history past 6 month &gt; 5 py history Current symptoms allergic rhinitis Current previous history significant respiratory disease ( asthma ) Any clinically relevant abnormality screen detect significant systemic disease Pregnant breastfeed woman Contact infant elderly home work Exacerbation virus within previous 6 week Treatment oral steroid previous 3 month Current use nasal spray , antihistamine , antileukotriene Antibodies rhinovirus 16 titre &gt; 1:2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2010</verification_date>
</DOC>